Table 3.

Univariate analysis of disease-free survival in Gastric carcinoma

Parameter	Disease-free survival, P value a
Age
<59 vs. ≥59	0.031
Gender
Male vs. female	0.433
CEA mRNA
(+) vs. (-)	0.001
Serum CEA
(+) vs. (-)	0.045
Histological grade
Well/moderately vs. poorly	0.022
pT
pTis/pT1 vs. pT2/pT3/pT4	<0.001
pN
(+) vs. (-)	0.001
Stage
1/2 vs. 3/4	<0.001
Adjuvant chemotherapy agents
CAPOX vs. mFOLFOX6 vs. Taxol+DDP vs. Taxol+5Fu/CF	0.850

^a Log-rank test